{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-23-000053","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.493240+00:00","generated_at":"2026-06-19T03:24:12.669008+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Chemed Q4 2022 adjusted EPS $5.39 (+2.7% YoY); guides 2023 adjusted EPS $20.75-$21.10","bullets":["Consolidated revenue $547M (+1.0% YoY); GAAP diluted EPS $4.13; adjusted diluted EPS $5.39.","VITAS net patient revenue $308M (-2.5%); ADC 17,434 (-2.8%); admissions -8.7%; adjusted EBITDA margin 19.8% (-189bps).","Roto-Rooter revenue $239M (+6.1%); adjusted EBITDA $69.3M (+11.4%); margin 29.0% (+138bps).","2023 guidance: VITAS revenue +6-7%, ADC +3.5-4%; Roto-Rooter revenue +5-5.5%; adjusted EPS $20.75-$21.10.","Share repurchases: 25,000 shares for $13.0M in Q4; $88M remaining authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-23-000053","json":"https://secwatch.observer/filing/0001562762-23-000053.json","markdown":"https://secwatch.observer/filing/0001562762-23-000053.md","text":"https://secwatch.observer/filing/0001562762-23-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/0001562762-23-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/che-20230223x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T03:24:12.669008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25358deae12a043f8e69d2e5d8832e023b847fc7","claim":"CHEMED CORP reported the fourth quarter ended December 31, 2022 results: revenue $547 million, EPS $4.13. Guidance initiated.","evidence_excerpt":"Chemed Corporation (Chemed) (NYSE: CHE ), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2022, versus the comparable prior-year period, as follows:  Consolidated operating results: · Revenue increased 1.0% to $547 million · GAAP Diluted Earnings-per-Share (EPS) of $4.13 · Adjusted Diluted EPS of $5.39","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/0001562762-23-000053-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$547 million"},{"label":"EPS","value":"$4.13"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}